Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students
- PMID: 33644891
- PMCID: PMC8013865
- DOI: 10.1002/jmv.26910
Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students
Abstract
Background: Vaccine hesitancy poses serious challenges for achieving coverage for population immunity. It is necessary to achieve high COVID-19 vaccination acceptance rates and medical students' coverage as future health care providers. The study aimed to explore the level of COVID-19 vaccine hesitancy and determine the factors and barriers that may affect vaccination decision-making.
Methods: A cross-sectional study was carried out among medical students in Tanta and Kafrelsheikh Universities, Egypt. Data collection was done via an online questionnaire during January 2021 from 2133 students.
Results: The majority of the participant students (90.5%) perceived the importance of the COVID-19 vaccine, 46% had vaccination hesitancy, and an equal percentage (6%) either definitely accepted or refused the vaccine. Most of the students had concerns regarding the vaccine's adverse effects (96.8%) and ineffectiveness (93.2%). The most confirmed barriers of COVID-19 vaccination were deficient data regarding the vaccine's adverse effects (potential 74.17% and unknown 56.31%) and insufficient information regarding the vaccine itself (72.76%).
Conclusion: The government, health authority decision-makers, medical experts, and universities in Egypt need to work together and make efforts to reduce hesitancy and raise awareness about vaccinations, consequently improving the acceptance of COVID-19 vaccines.
Keywords: COVID-19; medical students; vaccine acceptance; vaccine hesitancy.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
Authors declare no known competing conflicts of interest.
Figures
References
-
- Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580:576‐577. - PubMed
-
- Sharun K, Tiwari R, Iqbal Yatoo M, et al. Antibodybased immunotherapeutics and use of convalescent plasma to counter COVID‐19: advances and prospects. Expert Opin Biol Ther. 2020d;20(9):1033‐1046. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical